Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
664 Views
PTI 09 January 2023
The massive surge in COVID cases in China has resulted in a sharp increase in demand for Indian generic medications in the country. However, several doctors have issued warnings regarding counterfeit COVID-19 medications flooding the market these days. On Sunday, the National Health Security Administration in China stated that Pfizer′s Paxlovid oral medication was not included in the "register of drugs in the basic medical insurance" because the company′s quotation was too high.
As a result, the demand for Indian generic versions has gone up through Chinese e-commerce platforms. They stated that at least four generic COVID drugs produced in India, namely Primovir, Paxista, Molnunat, and Molnatris, have been listed for sale in recent weeks on several e-commerce sites. Primovir and Paxista are both generic versions of Paxlovid, while the other two are generic versions of Molnipiravir.
The head of Beijing Memorial Pharmaceutical, Dr. He Xiaobing, claimed that India was the only nation where they could find trustworthy and inexpensive COVID medications with assured therapeutic outcomes.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Detecting Intra-abdominal Adhesions in Women with Repeated C-sections..
Maintaining Liver Health to Optimize Glycemic Outcomes in Early Type 2.....
Antibiotic Prescribing Practices for Pediatric Acute Otitis Media..
Hidden Hazard of Indoor Pollution in COPD..
Recognizing Pitfalls of Point-of-Care Lung Ultrasound..
{{Article_Title}}..
Bombay HC Questions Denial of Motherhood to Woman with Intellectual Disability..
HMPV Outbreak in India: Health Minister Warns of Similar Symptoms to COVID-19, States Prepare Special ICU Wards..
Maharashtra Medical Education Minister Warns Children and Elderly to Stay Alert amid HMPV Cases..
Medical Negligence in Rewa: Surgical Needle Left inside Woman's Abdomen for Two Years..
HMPV in India: Seven Cases Reported across Four States..